Terms: = Bone cancer AND MSN, P26038, 4478, ENSG00000147065
14 results:
1. Ultrasound-Triggered Azo Free Radicals for Cervical cancer Immunotherapy.
Wang Y; Lv B; Wang H; Ren T; Jiang Q; Qu X; Ni D; Qiu J; Hua K
ACS Nano; 2024 Apr; 18(17):11042-11057. PubMed ID: 38627898
[TBL] [Abstract] [Full Text] [Related]
2. MicroRNA-146a-loaded magnesium silicate nanospheres promote bone regeneration in an inflammatory microenvironment.
Yang J; Shuai J; Siow L; Lu J; Sun M; An W; Yu M; Wang B; Chen Q
Bone Res; 2024 Jan; 12(1):2. PubMed ID: 38221522
[TBL] [Abstract] [Full Text] [Related]
3. Preclinical Assessment of ADAM9-Responsive Mesoporous Silica Nanoparticles for the Treatment of Pancreatic cancer.
Slapak EJ; El Mandili M; Brink MST; Kros A; Bijlsma MF; Spek CA
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445886
[TBL] [Abstract] [Full Text] [Related]
4. Selenium-incorporated mesoporous silica nanoparticles for osteosarcoma therapy.
He L; Habibovic P; van Rijt S
Biomater Sci; 2023 May; 11(11):3828-3839. PubMed ID: 37074160
[TBL] [Abstract] [Full Text] [Related]
5. Multifunctional mesoporous silica nanoparticles for pH-response and photothermy enhanced osteosarcoma therapy.
Shi Q; Lu Y; Zhang G; Yang X; Li R; Zhang G; Guo X; Song J; Ding Q
Colloids Surf B Biointerfaces; 2022 Sep; 217():112615. PubMed ID: 35759893
[TBL] [Abstract] [Full Text] [Related]
6. Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling.
Sun X; Li K; Hase M; Zha R; Feng Y; Li BY; Yokota H
Theranostics; 2022; 12(2):929-943. PubMed ID: 34976221
[No Abstract] [Full Text] [Related]
7. Endogenous Copper for Nanocatalytic Oxidative Damage and Self-Protection Pathway Breakage of cancer.
Guo Y; Xu Y; Bao Q; Shen C; Ni D; Hu P; Shi J
ACS Nano; 2021 Oct; 15(10):16286-16297. PubMed ID: 34652919
[TBL] [Abstract] [Full Text] [Related]
8. Loss of XIST in Breast cancer Activates msn-c-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis.
Xing F; Liu Y; Wu SY; Wu K; Sharma S; Mo YY; Feng J; Sanders S; Jin G; Singh R; Vidi PA; Tyagi A; Chan MD; Ruiz J; Debinski W; Pasche BC; Lo HW; Metheny-Barlow LJ; D'Agostino RB; Watabe K
Cancer Res; 2018 Aug; 78(15):4316-4330. PubMed ID: 30026327
[TBL] [Abstract] [Full Text] [Related]
9. Facile Synthesis of Chitosan Capped Mesoporous Silica Nanoparticles: A pH Responsive Smart Delivery Platform for Raloxifene Hydrochloride.
Shah PV; Rajput SJ
AAPS PharmSciTech; 2018 Apr; 19(3):1344-1357. PubMed ID: 29340980
[TBL] [Abstract] [Full Text] [Related]
10. CT and MRI of radiation-induced sarcomas of the head and neck following radiotherapy for nasopharyngeal carcinoma.
Cai PQ; Wu YP; Li L; Zhang R; Xie CM; Wu PH; Xu JH
Clin Radiol; 2013 Jul; 68(7):683-9. PubMed ID: 23477476
[TBL] [Abstract] [Full Text] [Related]
11. Smad inhibition by the Ste20 kinase Misshapen.
Kaneko S; Chen X; Lu P; Yao X; Wright TG; Rajurkar M; Kariya K; Mao J; Ip YT; Xu L
Proc Natl Acad Sci U S A; 2011 Jul; 108(27):11127-32. PubMed ID: 21690388
[TBL] [Abstract] [Full Text] [Related]
12. Targeted radiotherapy of bone malignancies.
Jansen DR; Krijger GC; Kolar ZI; Zonnenberg BA; Zeevaart JR
Curr Drug Discov Technol; 2010 Dec; 7(4):233-46. PubMed ID: 21034411
[TBL] [Abstract] [Full Text] [Related]
13. Aspirin and compression devices versus low-molecular-weight heparin and PCD for VTE prophylaxis in orthopedic oncology patients.
Patel AR; Crist MK; Nemitz J; Mayerson JL
J Surg Oncol; 2010 Sep; 102(3):276-81. PubMed ID: 20740587
[TBL] [Abstract] [Full Text] [Related]
14. Characterization of human neuroblastoma cell lines established before and after therapy.
Reynolds CP; Biedler JL; Spengler BA; Reynolds DA; Ross RA; Frenkel EP; Smith RG
J Natl Cancer Inst; 1986 Mar; 76(3):375-87. PubMed ID: 3456456
[TBL] [Abstract] [Full Text] [Related]
